These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 1895310

  • 1. A selective, reversible, competitive inhibitor of monoamine oxidase A containing no nitrogen, with negligible potentiation of tyramine-induced blood pressure rise.
    Harfenist M, McGee DP, White HL.
    J Med Chem; 1991 Sep; 34(9):2931-3. PubMed ID: 1895310
    [No Abstract] [Full Text] [Related]

  • 2. Preclinical and early clinical studies with BW 1370U87, a reversible competitive MAO-A inhibitor.
    White HL, Ascher JA.
    Clin Neuropharmacol; 1992 Sep; 15 Suppl 1 Pt A():343A-344A. PubMed ID: 1354041
    [No Abstract] [Full Text] [Related]

  • 3. Selective inhibitors of monoamine oxidase (MAO). 5. 1-Substituted phenoxathiin inhibitors containing no nitrogen that inhibit MAO A by binding it to a hydrophobic site.
    Harfenist M, McGee DP, Reeves MD, White HL.
    J Med Chem; 1998 Jun 04; 41(12):2118-25. PubMed ID: 9622553
    [Abstract] [Full Text] [Related]

  • 4. The effect of various monoamine oxidase (MAO) inhibitors on the response of blood pressure of rats and cats to tyramine.
    Abdo-Rubo A.
    Acta Physiol Hung; 1990 Jun 04; 75(4):321-36. PubMed ID: 2127505
    [Abstract] [Full Text] [Related]

  • 5. [The comparative influence of pyrazidol, inkazan and other antidepressant monoamine oxidase inhibitors on the pressor effect of tyramine].
    Andreeva NI, Golovina SM, Faermark MF, Shvarts GIa, Mashkovskiĭ MD.
    Farmakol Toksikol; 1991 Jun 04; 54(2):38-40. PubMed ID: 1884793
    [Abstract] [Full Text] [Related]

  • 6. Biochemical and pharmacological evaluation of 2,4-difluorobenzyldimethylsilylmethanamine, a new highly selective inhibitor of monoamine oxidase-B.
    Danzin C, Zreika M, Marchal P, Petty M, Collard JN, Schirlin D.
    Biochem Soc Trans; 1994 Aug 04; 22(3):768-73. PubMed ID: 7821682
    [No Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
    Bieck PR, Antonin KH, Schmidt E.
    Clin Neuropharmacol; 1993 Aug 04; 16 Suppl 2():S34-41. PubMed ID: 8313395
    [Abstract] [Full Text] [Related]

  • 8. Relationship between tyramine potentiation and selective inhibition of monoamine oxidase types A and B in the rat vas deferens.
    Finberg JP, Tenne M.
    Br J Pharmacol; 1982 Sep 04; 77(1):13-21. PubMed ID: 6127132
    [Abstract] [Full Text] [Related]

  • 9. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to intravenous tyramine in man.
    Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A, Braibanti E.
    Br J Clin Pharmacol; 1981 Jun 04; 11(6):605-10. PubMed ID: 7272177
    [Abstract] [Full Text] [Related]

  • 10. Preclinical and early clinical studies with BW 1370U87, a reversible competitive monoamine oxidase-A inhibitor.
    White HL, Ascher JA.
    Clin Neuropharmacol; 1993 Jun 04; 16 Suppl 2():S25-33. PubMed ID: 8313394
    [Abstract] [Full Text] [Related]

  • 11. [Potentiation by monoamine oxidase inhibitors of the pressor effect of tyramine and of alpha-methyl-m-tyramine].
    Gessa GL.
    Arch Ital Sci Farmacol; 1964 Jun 04; 14(3):275-9. PubMed ID: 5880662
    [No Abstract] [Full Text] [Related]

  • 12. Cardiovascular changes in response to selective monoamine oxidase inhibition in the rat.
    Cohen RM, Campbell IC, Yamaguchi I, Pickar D, Kopin IJ, Murphy DL.
    Eur J Pharmacol; 1982 May 07; 80(1):155-60. PubMed ID: 6284529
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation.
    Youdim MB, Weinstock M.
    Neurotoxicology; 2004 Jan 07; 25(1-2):243-50. PubMed ID: 14697899
    [Abstract] [Full Text] [Related]

  • 14. Effect of monoamine oxidase inhibitors and pyrogallol on the pressor response to adrenaline, noradrenaline, normetanephrine and tyramine in the rat.
    VANOV S.
    Arch Int Pharmacodyn Ther; 1962 Jul 01; 138():51-61. PubMed ID: 13924773
    [No Abstract] [Full Text] [Related]

  • 15. Effects of caroxazone, a reversible monoamine oxidase inhibitor, on the pressor response to oral tyramine in man.
    Martini A, Bonollo L, Nicolis FB, Sega R, Palermo A.
    Br J Clin Pharmacol; 1981 Jun 01; 11(6):611-5. PubMed ID: 7272178
    [Abstract] [Full Text] [Related]

  • 16. [Monoamine oxidase inhibitors and pressor response to dietary amines].
    Tipton KF.
    Vopr Med Khim; 1997 Jun 01; 43(6):494-503. PubMed ID: 9503566
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic interaction between toloxatone, a new reversible monoamine oxidase-A inhibitor, and oral tyramine in healthy subjects.
    Provost JC, Funck-Brentano C, Rovei V, D'Estanque J, Ego D, Jaillon P.
    Clin Pharmacol Ther; 1992 Oct 01; 52(4):384-93. PubMed ID: 1424410
    [Abstract] [Full Text] [Related]

  • 18. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P, Pauwels G, Buyse C, David-Remacle M, De Mey J, Roba J, Youdim MB.
    J Neurochem; 1989 Oct 01; 53(4):1109-16. PubMed ID: 2769256
    [Abstract] [Full Text] [Related]

  • 19. Microsomal enzymes and potentiation of tyramine pressor response.
    Renton KW, Eade NR.
    Biochem Pharmacol; 1972 May 15; 21(10):1393-402. PubMed ID: 5029421
    [No Abstract] [Full Text] [Related]

  • 20. [Action of some derivatives of pyrazolinone on the pressor activity of tyramine].
    Patané S, Arrigo Reina R.
    Boll Soc Ital Biol Sper; 1969 Aug 31; 45(16):1081-3. PubMed ID: 5374943
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.